Santen Of Japan Launches Eye Drug For Inspire Of U.S.
This article was originally published in PharmAsia News
Executive Summary
Japan's Santen Pharmaceutical launched a U.S.-made drug to treat dry eyes in Japan for Inspire Pharmaceuticals, earning a $1.25 million milestone payment from the American drug maker